Summarized Financial Information Concerning Reportable Segments |
Summarized
financial information concerning reportable segments is shown in the following tables:
Three Months Ended September 30, 2021
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
19,063,077
|
|
|
$
|
1,581,765
|
|
|
$
|
35,708
|
|
|
$
|
20,680,550
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
18,695,783
|
|
|
|
1,599,430
|
|
|
|
-
|
|
|
|
20,295,213
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(7,456,129
|
)
|
|
|
(3,163,886
|
)
|
|
|
(3,817,061
|
)
|
|
|
(14,437,076
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense), net
|
|
|
22,822
|
|
|
|
(1,597
|
)
|
|
|
(3,297,103
|
)
|
|
|
(3,275,878
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(7,433,307
|
)
|
|
|
(3,165,483
|
)
|
|
|
(7,114,164
|
)
|
|
|
(17,712,954
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
1,064,757
|
|
|
|
356,233
|
|
|
|
1,174
|
|
|
|
1,422,164
|
|
Total assets
|
|
|
189,019,883
|
|
|
|
22,273,264
|
|
|
|
27,347,259
|
|
|
|
238,640,406
|
|
Three Months Ended September 30, 2020
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
9,026,323
|
|
|
$
|
1,214,327
|
|
|
$
|
35,708
|
|
|
$
|
10,276,358
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
10,625,837
|
|
|
|
1,229,627
|
|
|
|
-
|
|
|
|
11,855,464
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(9,277,702
|
)
|
|
|
(1,320,461
|
)
|
|
|
(3,202,814
|
)
|
|
|
(13,800,977
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(268,023
|
)
|
|
|
(411
|
)
|
|
|
(2,848,042
|
)
|
|
|
(3,116,476
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(9,545,725
|
)
|
|
|
(1,320,872
|
)
|
|
|
(6,050,856
|
)
|
|
|
(16,917,453
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization expense
|
|
|
863,366
|
|
|
|
169,691
|
|
|
|
2,236
|
|
|
|
1,035,293
|
|
Total assets
|
|
|
125,004,813
|
|
|
|
9,358,823
|
|
|
|
55,612,407
|
|
|
|
189,976,043
|
|
Nine Months Ended September 30, 2021
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
48,832,000
|
|
|
$
|
5,620,633
|
|
|
$
|
107,125
|
|
|
$
|
54,559,758
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
51,527,832
|
|
|
|
5,370,127
|
|
|
|
-
|
|
|
|
56,897,959
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(25,299,223
|
)
|
|
|
(7,928,946
|
)
|
|
|
(11,954,388
|
)
|
|
|
(45,182,557
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(77,484
|
)
|
|
|
(2,349
|
)
|
|
|
(9,735,808
|
)
|
|
|
(9,815,641
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(25,376,707
|
)
|
|
|
(7,931,295
|
)
|
|
|
(21,690,196
|
)
|
|
|
(54,998,198
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
3,805,472
|
|
|
|
6,029,932
|
|
|
|
-
|
|
|
|
9,835,404
|
|
Depreciation and amortization expense
|
|
|
3,130,064
|
|
|
|
843,151
|
|
|
|
4,571
|
|
|
|
3,977,786
|
|
Nine Months Ended September 30, 2020
|
|
|
|
ADMA
BioManufacturing
|
|
|
Plasma Collection
Centers
|
|
|
Corporate
|
|
|
Consolidated
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
|
$
|
23,272,463
|
|
|
$
|
4,884,108
|
|
|
$
|
107,125
|
|
|
$
|
28,263,696
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of product revenue
|
|
|
37,314,930
|
|
|
|
4,865,389
|
|
|
|
-
|
|
|
|
42,180,319
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
|
|
(34,606,679
|
)
|
|
|
(2,696,927
|
)
|
|
|
(10,390,982
|
)
|
|
|
(47,694,588
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other expense, net
|
|
|
(742,336
|
)
|
|
|
(444
|
)
|
|
|
(7,903,406
|
)
|
|
|
(8,646,186
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
|
(35,349,015
|
)
|
|
|
(2,697,371
|
)
|
|
|
(18,294,388
|
)
|
|
|
(56,340,774
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
6,619,399
|
|
|
|
2,508,960
|
|
|
|
-
|
|
|
|
9,128,359
|
|
Depreciation and amortization expense
|
|
|
2,310,580
|
|
|
|
392,086
|
|
|
|
7,117
|
|
|
|
2,709,783
|
|
|